2,5-dichloro-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-N-pentylbenzamide
C25H28Cl2FN3O — CID 18732498
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,5-dichloro-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-N-pentylbenzamide
2,5-dichloro-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-N-pentylbenzamide (PubChem CID 18732498) has the molecular formula C25H28Cl2FN3O and a molecular weight of 476.42 g/mol. Its IUPAC name is 2,5-dichloro-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-N-pentylbenzamide.
Molecular Properties
| Compound Name | 2,5-dichloro-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-N-pentylbenzamide |
|---|---|
| PubChem CID | 18732498 |
| Molecular Formula | C25H28Cl2FN3O |
| Molecular Weight | 476.42 g/mol |
| Exact Mass | 475.16 |
| IUPAC Name | 2,5-dichloro-N-[(1-cyclopentyl-5-fluorobenzimidazol-2-yl)methyl]-N-pentylbenzamide |
| SMILES | CCCCCN(Cc1nc2cc(F)ccc2n1C1CCCC1)C(=O)c1cc(Cl)ccc1Cl |
| InChI | InChI=1S/C25H28Cl2FN3O/c1-2-3-6-13-30(25(32)20-14-17(26)9-11-21(20)27)16-24-29-22-15-18(28)10-12-23(22)31(24)19-7-4-5-8-19/h9-12,14-15,19H,2-8,13,16H2,1H3 |
| InChIKey | YSYSTQCRYKQZMG-UHFFFAOYSA-N |
| XLogP | 7.43 |
| TPSA | 38.13 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.42 |
| LogP ≤ 5 | 7.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 18732498 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.